Patents by Inventor Christopher Lee Parks

Christopher Lee Parks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine Compositions For Preventing Coronavirus Disease
    Publication number: 20210338804
    Abstract: The present disclosure provides Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) vaccines, recombinant vesicular stomatitis virus (VSV) vectors encoding the SARS-CoV-2 spike (S) protein or an immunogenic variant thereof, recombinant replicable VSV particles having a SARS-CoV-2 S protein or an immunogenic variant thereof on the surface of the particles, and immunogenic recombinant proteins comprising a SARS-CoV-2 S protein or a variant thereof. Immunogenic compositions comprising the SARS-CoV-2 vaccines, the recombinant VSV vectors, the recombinant replicable VSV particles and/or the immunogenic recombinant proteins may be used for inducing an immune response to the SARS-CoV-2, preventing infection by the SARS-CoV-2, vaccinating against the SARS-CoV-2 and/or producing adaptive mutants of the recombinant replicable VSV particles.
    Type: Application
    Filed: February 19, 2021
    Publication date: November 4, 2021
    Applicants: International AIDS Vaccine Initiative Inc., Merck Sharp & Dohme Corp.
    Inventors: Christopher Lee Parks, Maoli Yuan, Mark Feinberg, Amy Espeseth, Andrew J. Bett
  • Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
    Patent number: 8647638
    Abstract: The present invention broadly relates to the synergistic attenuation of vesicular stomatitis virus (VSV), More particularly, the invention relates to the identification of combined mutation classes which synergistically attenuate the pathogenicity of VSV vectors in mammals and immunogenic compositions thereof.
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: February 11, 2014
    Assignee: Wyeth LLC
    Inventors: David Kirkwood Clarke, Roger Michael Hendry, Stephen A. Udem, Christopher Lee Parks
  • Synergistic Attenuation of Vesicular Stomatitis Virus, Vectors Thereof and Immunogenic Compositions Thereof
    Publication number: 20130023032
    Abstract: The present invention broadly relates to the synergistic attenuation of vesicular stomatitis virus (VSV), More particularly, the invention relates to the identification of combined mutation classes which synergistically attenuate the pathogenicity of VSV vectors in mammals and immunogenic compositions thereof.
    Type: Application
    Filed: August 31, 2012
    Publication date: January 24, 2013
    Applicant: Wyeth LLC
    Inventors: David Kirkwood Clarke, Roger Michael Hendry, Stephen A. Udem, Christopher Lee Parks
  • Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
    Patent number: 8287878
    Abstract: The present invention broadly relates to the synergistic attenuation of vesicular stomatitis virus (VSV). More particularly, the invention relates to the identification of combined mutation classes which synergistically attenuate the pathogenicity of VSV vectors in mammals and immunogenic compositions thereof.
    Type: Grant
    Filed: April 5, 2005
    Date of Patent: October 16, 2012
    Assignee: Wyeth LLC
    Inventors: David Kirkwood Clarke, Roger Michael Hendry, Stephen A. Udem, Christopher Lee Parks